18 June 2013
Keywords: halo, names, george, bobotas, cso, deal, demelle
Article | 23 April 2009
US firm Halo Pharmaceutical has named George Bobotas chief scientific officer. The move is part of the firm's R&D ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
© 2013 thepharmaletter.com